West Nile virus in Europe: Emergence, epidemiology, diagnosis, treatment, and prevention

Clinical Microbiology and Infection

Volumn 19, Issue 8, 2013, Pages 699-704

  Sambri, V ^a,b   Capobianchi, M ^c   Charrel, R ^d,e   Fyodorova, M ^f   Gaibani, P ^g   Gould, E ^d,e,h   Niedrig, M ⁱ   Papa, A ^j   Pierro, A ^g   Rossini, G ^g   Varani, S ^a   Vocale, C ^g   Landini, M P ^a,g  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Unit of Microbiology   (Italy)

^c NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^d Aix Marseille University IRD 190 Inserm 1207   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^f CENTRAL RESEARCH INSTITUTE OF EPIDEMIOLOGY   (Russian Federation)

^g UNIVERSITY OF BOLOGNA   (Italy)

^h CENTRE FOR ECOLOGY AND HYDROLOGY   (United Kingdom)

ⁱ ROBERT KOCH INSTITUTE   (Germany)

^j ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

more..

Author keywords

Clinical features; Emerging infections; Epidemiology; Mosquito borne infections; Prevention; West Nile virus

Indexed keywords

ANTIVIRUS AGENT; IMMUNOGLOBULIN; WEST NILE VACCINE;

ANTIVIRAL THERAPY; BLOOD SAMPLING; BLOOD TRANSFUSION; CEREBROSPINAL FLUID ANALYSIS; ENZYME IMMUNOASSAY; EPIDEMIC; EUROPE; HUMAN; IMMUNOFLUORESCENCE TEST; INFECTION CONTROL; MORBIDITY; NONHUMAN; ORGAN DONOR; PHYLOGENY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; VACCINATION; VIRUS ENCEPHALITIS; WEST NILE ENCEPHALITIC DISEASE; WEST NILE FEVER; WEST NILE FLAVIVIRUS;

AVES; EQUIDAE; FLAVIVIRUS; JAPANESE ENCEPHALITIS VIRUS; WEST NILE VIRUS;

EID: 84880511511     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12211     Document Type: Review

References (51)

1. Hubalek Z, Halouzka J. West Nile fever-a reemerging mosquito-borne viral disease in Europe. Emerg Infect Dis 1999; 5: 643-650.
2. Rossi SL, Ross TM, Evans JD. West Nile virus. Clin Lab Med 2010; 30: 47-65.
3. Kramer LD, Li J, Shi PY. West Nile virus. Lancet Neurol 2007; 6: 171-181.
4. Angelini P, Tamba M, Finarelli AC et al. West Nile virus circulation in Emilia-Romagna, Italy: the integrated surveillance system 2009. Euro Surveill 2010; 15: 19547.
5. Reiter P. West Nile virus in Europe: understanding the present to gauge the future. Euro Surveill 2010; 15: 19508.
6. Kilpatrick AM. Globalization, land use, and the invasion of West Nile virus. Science 2011; 334: 323-327.
7. Platonov AE, Shipulin GA, Shipulina OY et al. Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999. Emerg Infect Dis 2001; 7: 128-132.
8. Zeller HG, Schuffenecker I. West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas. Eur J Clin Microbiol Infect Dis 2004; 23: 147-156.
9. Platonov AE, Karan LS, Shopenskaia TA et al. Genotyping of West Nile fever virus strains circulating in southern Russia as an epidemiological investigation method: principles and results. Zh Mikrobiol Epidemiol Immunobiol 2011; 2: 29-37.
10. Ulbert S. West Nile virus: the complex biology of an emerging pathogen. Intervirology 2011; 54: 171-184.
11. Dauphin G, Zientara S. West Nile virus: recent trends in diagnosis and vaccine development. Vaccine 2007; 25: 5563-5576.
12. Rossini G, Cavrini F, Pierro A et al. First human case of West Nile virus neuroinvasive infection in Italy, September 2008-case report. Euro Surveill 2008; 13: pii: 19002.
13. Bofill D, Domingo C, Cardenosa N et al. Human West Nile virus infection, Catalonia, Spain. Emerg Infect Dis 2006; 12: 1163-1164.
14. Bernabeu-Wittel M, Ruiz-Perez M, del Toro MD et al. West Nile virus past infections in the general population of southern Spain. Enferm Infecc Microbiol Clin 2007; 25: 561-565.
15. Esteves A, Almeida AP, Galao RP et al. West Nile virus in southern Portugal, 2004. Vector Borne Zoonotic Dis 2005; 5: 410-413.
16. Barros SC, Ramos F, Fagulha T et al. Serological evidence of West Nile virus circulation in Portugal. Vet Microbiol 2011; 152: 407-410.
17. Garcia-Bocanegra I, Jaen-Tellez JA, Napp S et al. West Nile fever outbreak in horses and humans, Spain, 2010. Emerg Infect Dis 2011; 17: 2397-2399.
18. Buckley A, Dawson A, Moss SR, Hinsley SA, Bellamy PE, Gould EA. Serological evidence of West Nile virus, Usutu virus and Sindbis virus infection of birds in the UK. J Gen Virol 2003; 84: 2807-2817.
19. Buckley A, Dawson A, Gould EA. Detection of seroconversion to West Nile virus, Usutu virus and Sindbis virus in UK sentinel chickens. Virol J 2006; 3: 71.
20. Sonnleitner ST, Simeoni J, Schmutzhard E et al. Absence of indigenous specific West Nile virus antibodies in Tyrolean blood donors. Eur J Clin Microbiol Infect Dis 2012; 31: 77-81.
21. Koppelman MH, Sjerps MS, de Waal M, Reesink HW, Cuypers HT. No evidence of West Nile virus infection in Dutch blood donors. Vox Sang 2006; 90: 166-169.
22. Rabel PO, Planitzer CB, Farcet MR et al. Increasing West Nile virus antibody titres in central European plasma donors from 2006 to 2010. Euro Surveill 2011; 16: 19812.
23. Bakonyi T, Ivanics E, Erdelyi K et al. Lineage 1 and 2 strains of encephalitic West Nile virus, central Europe. Emerg Infect Dis 2006; 12: 618-623.
24. Papa A, Xanthopoulou K, Gewehr S, Mourelatos S. Detection of West Nile virus lineage 2 in mosquitoes during a human outbreak in Greece. Clin Microbiol Infect 2011; 17: 1176-1180.
25. Papa A, Bakonyi T, Xanthopoulou K, Vazquez A, Tenorio A, Nowotny N. Genetic characterization of West Nile virus lineage 2, Greece, 2010. Emerg Infect Dis 2011; 17: 920-922.
26. Bagnarelli P, Marinelli K, Trotta D et al. Human case of autochthonous West Nile virus lineage 2 infection in Italy, September 2011. Euro Surveill 2011; 16: pii: 20002.
27. Magurano F, Remoli ME, Baggieri M et al. Circulation of West Nile virus lineage 1 and 2 during an outbreak in Italy. Clin Microbiol Infect 2012; 18: E545-E547.
28. Charrel RN, Brault AC, Gallian P et al. Evolutionary relationship between Old World West Nile virus strains. Evidence for viral gene flow between Africa, the Middle East, and Europe. Virology 2003; 315: 381-388.
29. Rossini G, Carletti F, Bordi L et al. Phylogenetic analysis of West Nile virus isolates, Italy, 2008-2009. Emerg Infect Dis 2011; 17: 903-906.
30. Barzon L, Pacenti M, Franchin E et al. New endemic West Nile virus lineage 1a in northern Italy, July 2012. Euro Surveill 2012; 17: pii: 20231.
31. Rossini G, Carletti F, Rigoli R et al. Heterogeneity of West Nile virus genotype 1a in Italy, 2011. J Gen Virol 2013; 94: 314-317.
32. Papa A. West Nile virus infections in Greece: an update. Expert Rev Anti-infect Ther 2012; 10: 743-750.
33. Rizzo C, Salcuni P, Nicoletti L et al. Epidemiological surveillance of West Nile neuroinvasive diseases in Italy, 2008 to 2011. Euro Surveill 2012; 17: pii: 20172.
34. Barzon L, Pacenti M, Cusinato R et al. Human cases of West Nile Virus infection in north-eastern Italy, 15 June to 15 November 2010. Euro Surveill 2011;16: pii: 19949.
35. Barzon L, Pacenti M, Franchin E et al. Clinical and virological findings in the ongoing outbreak of West Nile virus Livenza strain in northern Italy, July to September 2012. Euro Surveill 2012; 17: pii: 20260.
36. Gyure KA. West Nile virus infections. J Neuropathol Exp Neurol 2009; 68: 1053-1060.
37. Rhee C, Eaton EF, Concepcion W, Blackburn BG. West Nile virus encephalitis acquired via liver transplantation and clinical response to intravenous immunoglobulin: case report and review of the literature. Transpl Infect Dis 2011; 13: 312-317.
38. Capobianchi MR, Sambri V, Castilletti C et al. Retrospective screening of solid organ donors in Italy, 2009, reveals unpredicted circulation of West Nile virus. Euro Surveill 2010; 15: pii: 19648.
39. Morelli MC, Sambri V, Grazi GL et al. Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. Clin Infect Dis 2010; 51: e34-e37.
40. Costa AN, Capobianchi MR, Ippolito G et al. West Nile virus: the Italian national transplant network reaction to an alert in the north-eastern region, Italy 2011. Euro Surveill 2011; 16: pii: 19991.
41. De Filette M, Ulbert S, Diamond M, Sanders NN. Recent progress in West Nile virus diagnosis and vaccination. Vet Res 2012; 43: 16.
42. Pierson TC, Diamond MS. Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection. Expert Rev Mol Med 2008; 10: e12.
43. Lindsey HS, Calisher CH, Mathews JH. Serum dilution neutralization test for California group virus identification and serology. J Clin Microbiol 1976; 4: 503-510.
44. Monini M, Falcone E, Busani L, Romi R, Ruggeri FM. West nile virus: characteristics of an African virus adapting to the third millennium world. Open Virol J 2010; 4: 42-51.
45. Pai A, Kleinman S, Malhotra K, Lee-Haynes L, Pietrelli L, Saldanha J. Performance characteristics of the Food and Drug Administration-licensed Roche Cobas TaqScreen West Nile virus assay. Transfusion 2008; 48: 2184-2189.
46. Ziermann R, Sanchez-Guerrero SA. PROCLEIX West Nile virus assay based on transcription-mediated amplification. Expert Rev Mol Diagn 2008; 8: 239-245.
47. Papa A, Politis C, Tsoukala A et al. West Nile virus lineage 2 from blood donor, Greece. Emerg Infect Dis 2012; 18: 688-689.
48. Minke JM, Siger L, Cupillard L et al. Protection provided by a recombinant ALVAC((R))-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain. Vaccine 2011; 29: 4608-4612.
49. Kaiser J. Public health. Outbreak pattern stymies vaccine work. Science 2012; 337: 1030.
50. Nolan MS, Podoll AS, Hause AM, Akers KM, Finkel KW, Murray KO. Prevalence of chronic kidney disease and progression of disease over time among patients enrolled in the Houston West Nile virus cohort. PLoS ONE 2012; 7: e40374.
51. Murray K, Walker C, Herrington E et al. Persistent infection with West Nile virus years after initial infection. J Infect Dis 2010; 201: 2-4.